T1	CHEM 1 12	Sufentanilo
#1	AnnotatorNotes T1	C0143993; sufentanil; Organic Chemical · Pharmacologic Substance
T2	PROC 700 726	procedimientos de urgencia
#2	AnnotatorNotes T2	C1298802; Emergency procedure; Therapeutic or Preventive Procedure
T3	PROC 29 60	revascularización del miocardio
#3	AnnotatorNotes T3	C0027056; Myocardial Revascularization; Therapeutic or Preventive Procedure
T4	PROC 86 102	cirugía cardíaca
#4	AnnotatorNotes T4	C0018821; Cardiac Surgery procedures; Therapeutic or Preventive Procedure
T5	PROC 115 143	revascularización miocárdica
#5	AnnotatorNotes T5	C0027056; Myocardial Revascularization; Therapeutic or Preventive Procedure
T6	PROC 148 173	circulación extracorpórea
#6	AnnotatorNotes T6	C0015354; Extracorporeal Circulation; Therapeutic or Preventive Procedure
T7	CHEM 235 246	sufentanilo
#7	AnnotatorNotes T7	C0143993; sufentanil; Organic Chemical · Pharmacologic Substance
T8	PROC 728 744	reintervenciones
T9	PROC 263 280	anestesia general
#8	AnnotatorNotes T9	C0002915; General Anesthesia; Therapeutic or Preventive Procedure
T10	PROC 294 337	estudio prospectivo, aleatorizado y abierto
#9	AnnotatorNotes T10	C0033522; Prospective Studies; Research Activity + C1709323; Open Label Study; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
T11	PROC 415 435	estudio monocéntrico
T12	PROC 620 637	revascularización
#10	AnnotatorNotes T12	C0581603; Revascularization - action; Therapeutic or Preventive Procedure
T13	DISO 674 698	enfermedad renal crónica
#11	AnnotatorNotes T13	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T14	PROC 787 832	fracción de eyección del ventrículo izquierdo
#12	AnnotatorNotes T14	C2114363; left ventricular ejection fraction assessment; Therapeutic or Preventive Procedure
T15	ANAT 812 832	ventrículo izquierdo
#13	AnnotatorNotes T15	C0225897; Left ventricular structure; Body Part, Organ, or Organ Component | C1269892; Entire left ventricle; Body Part, Organ, or Organ Component
T16	CHEM 906 920	nitroglicerina
#14	AnnotatorNotes T16	C0017887; nitroglycerin; Organic Chemical · Pharmacologic Substance
T17	PROC 923 937	Intervenciones
#15	AnnotatorNotes T17	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T18	CHEM 1007 1018	sufentanilo
#16	AnnotatorNotes T18	C0143993; sufentanil; Organic Chemical · Pharmacologic Substance
T19	CHEM 1410 1428	soporte inotrópico
#17	AnnotatorNotes T19	C5147552; Inotropic support; Pharmacologic Substance
T20	PROC 1034 1043	anestesia
#18	AnnotatorNotes T20	C0002903; Anesthesia procedures; Therapeutic or Preventive Procedure
T21	PROC 1071 1088	infusión continua
#19	AnnotatorNotes T21	C0444889; Continuous infusion; Therapeutic or Preventive Procedure
T22	CHEM 1092 1103	sevoflurano
#20	AnnotatorNotes T22	C0074414; sevoflurane; Organic Chemical · Pharmacologic Substance
T23	CHEM 1106 1119	remifentanilo
#21	AnnotatorNotes T23	C0246631; remifentanil; Organic Chemical · Pharmacologic Substance
T24	ANAT 1191 1201	sanguíneos
#22	AnnotatorNotes T24	C0005767; Blood; Body Substance
T25	CHEM 1205 1216	troponina i
#23	AnnotatorNotes T25	C0077401; Troponin I; Amino Acid, Peptide, or Protein · Biologically Active Substance
T26	ANAT 1217 1225	cardíaca
#24	AnnotatorNotes T26	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T27	PROC 1227 1258	péptido natriurético del tipo B
#25	AnnotatorNotes T27	C2082356; B-type natriuretic peptide; Laboratory Procedure
T28	PROC 1260 1274	interleucina 6
#26	AnnotatorNotes T28	C0919829; Interleukin 6 Measurement; Laboratory Procedure
T29	PROC 1277 1308	factor de necrosis tumoral alfa
#27	AnnotatorNotes T29	C1168005; Alpha tumour necrosis factor measurement; Laboratory Procedure
T30	PROC 576 600	consentimiento informado
#28	AnnotatorNotes T30	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T31	CHEM 1380 1391	sufentanilo
#29	AnnotatorNotes T31	C0143993; sufentanil; Organic Chemical · Pharmacologic Substance
T32	CHEM 1433 1441	dopamina
#30	AnnotatorNotes T32	C0013030; dopamine; Biologically Active Substance · Organic Chemical · Pharmacologic Substance
T33	CHEM 1528 1541	remifentanilo
#31	AnnotatorNotes T33	C0246631; remifentanil; Organic Chemical · Pharmacologic Substance
T34	CHEM 1743 1754	sufentanilo
#32	AnnotatorNotes T34	C0143993; sufentanil; Organic Chemical · Pharmacologic Substance
T35	CHEM 1830 1848	soporte inotrópico
#33	AnnotatorNotes T35	C5147552; Inotropic support; Pharmacologic Substance
T36	CHEM 1903 1911	opiáceos
#34	AnnotatorNotes T36	C0242402; Opioids; Hazardous or Poisonous Substance · Organic Chemical · Pharmacologic Substance | C0376196; Opiates; Hazardous or Poisonous Substance · Organic Chemical · Pharmacologic Substance
T37	ANAT 51 60	miocardio
#35	AnnotatorNotes T37	C0027061; Myocardium; Tissue | C1284309; Entire myocardium; Tissue
T38	ANAT 133 143	miocárdica
#36	AnnotatorNotes T38	C0027061; Myocardium; Tissue | C1284309; Entire myocardium; Tissue
T39	PROC 771 785	raquianestesia
#37	AnnotatorNotes T39	C0002928; Spinal Anesthesia; Therapeutic or Preventive Procedure
T40	ANAT 685 690	renal
#38	AnnotatorNotes T40	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T41	PROC 961 974	aleatorizados
#39	AnnotatorNotes T41	C0034656; Randomization; Research Activity
T42	PROC 850 873	índice de masa corporal
#40	AnnotatorNotes T42	C0005893; Body mass index procedure; Diagnostic Procedure | C3698309; Measurement of body mass index; Health Care Activity
T43	ANAT 865 873	corporal
#41	AnnotatorNotes T43	C0460148; Human body structure; Anatomical Structure | C1318419; Entire human body; Anatomical Structure
T44	PROC 1044 1053	se indujo
#42	AnnotatorNotes T44	C0857127; Induction procedure; Therapeutic or Preventive Procedure
T45	PROC 1183 1225	niveles sanguíneos de troponina i cardíaca
#43	AnnotatorNotes T45	C4027365; whole blood cardiac troponin I; Laboratory Procedure (?)
T46	PROC 1333 1340	cirugía
#44	AnnotatorNotes T46	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T47	Route 13 23	intratecal
#45	AnnotatorNotes T47	C0677897; Intrathecal Route of Drug Administration; Functional Concept
T48	LIVB 73 82	pacientes
#46	AnnotatorNotes T48	C0030705; Patients; Patient or Disabled Group
T49	PHYS 198 217	efecto hemodinámico
#47	AnnotatorNotes T49	C0019010; Hemodynamics; Organ or Tissue Function
T50	Route 247 257	intratecal
#48	AnnotatorNotes T50	C0677897; Intrathecal Route of Drug Administration; Functional Concept
T52	LIVB 514 523	Pacientes
#49	AnnotatorNotes T52	C0030705; Patients; Patient or Disabled Group
T53	LIVB 535 559	pacientes de ambos sexos
#50	AnnotatorNotes T53	C0030705; Patients; Patient or Disabled Group + C0025266; Male population group; Population Group + C0043210; Woman; Population Group
T54	Duration 691 698	crónica
#51	AnnotatorNotes T54	C0205191; chronic; Temporal Concept
T57	LIVB 944 953	pacientes
#52	AnnotatorNotes T57	C0030705; Patients; Patient or Disabled Group
T58	Dose 996 1003	1 µg/kg
T59	Route 1019 1029	intratecal
#53	AnnotatorNotes T59	C0677897; Intrathecal Route of Drug Administration; Functional Concept
T60	Route 1071 1079	infusión
#54	AnnotatorNotes T60	C1621368; Intravenous Drip Route of Administration; Functional Concept
T61	PHYS 1168 1181	hemodinámicas
#55	AnnotatorNotes T61	C0019010; Hemodynamics; Organ or Tissue Function
T62	LIVB 1360 1369	pacientes
#56	AnnotatorNotes T62	C0030705; Patients; Patient or Disabled Group
T63	LIVB 1460 1473	grupo control
#57	AnnotatorNotes T63	C0009932; Control Groups; Group
T64	PROC 1572 1591	datos hemodinámicos
#58	AnnotatorNotes T64	C4082936; Hemodynamic Monitoring; Health Care Activity
T67	LIVB 1718 1727	pacientes
#59	AnnotatorNotes T67	C0030705; Patients; Patient or Disabled Group
T68	Route 1755 1765	intratecal
#60	AnnotatorNotes T68	C0677897; Intrathecal Route of Drug Administration; Functional Concept
T69	PHYS 1791 1803	hemodinámica
#61	AnnotatorNotes T69	C0019010; Hemodynamics; Organ or Tissue Function
T70	Route 1887 1899	intravenosas
#62	AnnotatorNotes T70	C1522726; Intravenous Route of Drug Administration; Functional Concept
T71	PHYS 799 832	eyección del ventrículo izquierdo
#63	AnnotatorNotes T71	C2733342; Left ventricular ejection; Physiologic Function
T51	PROC 1507 1524	aumentos de dosis
#64	AnnotatorNotes T51	C1707810; Dose Increased; Therapeutic or Preventive Procedure
T55	PROC 1866 1886	ajustes en las dosis
#65	AnnotatorNotes T55	C2826232; Dose Adjustment; Health Care Activity
A1	Assertion T39 Contraindicated
T56	Neg_cue 1653 1655	no
T65	CONC 1668 1679	diferencias
A2	Assertion T65 Negated
#66	AnnotatorNotes T65	C1705241; Delta (difference); Quantitative Concept
R1	Negation Arg1:T56 Arg2:T65	
R2	Has_Route_or_Mode Arg1:T1 Arg2:T47	
R3	Before Arg1:T1 Arg2:T3	
R4	Location_of Arg1:T37 Arg2:T3	
R5	Experiences Arg1:T48 Arg2:T4	
R6	Experiences Arg1:T48 Arg2:T5	
R7	Location_of Arg1:T38 Arg2:T5	
R8	Combined_with Arg1:T5 Arg2:T6	
R9	Experiences Arg1:T48 Arg2:T6	
R10	Causes Arg1:T7 Arg2:T49	
R11	Has_Route_or_Mode Arg1:T7 Arg2:T50	
R12	Used_for Arg1:T7 Arg2:T9	
R13	Experiences Arg1:T53 Arg2:T12	
R14	Before Arg1:T30 Arg2:T12	
T66	Quantifier_or_Qualifier 638 646	electiva
#67	AnnotatorNotes T66	C0439608; elective; Temporal Concept
R15	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T66	
R16	Location_of Arg1:T40 Arg2:T13	
R17	Has_Duration_or_Interval Arg1:T13 Arg2:T54	
R19	Location_of Arg1:T15 Arg2:T71	
R20	Location_of Arg1:T15 Arg2:T14	
T72	Result_or_Value 833 848	inferior al 40%
R21	Has_Result_or_Value Arg1:T14 Arg2:T72	
R22	Location_of Arg1:T43 Arg2:T42	
T73	Result_or_Value 874 896	por encima de 32 kg/m2
R23	Has_Result_or_Value Arg1:T42 Arg2:T73	
R24	Experiences Arg1:T57 Arg2:T18	
R25	Has_Route_or_Mode Arg1:T18 Arg2:T59	
R26	Has_Dose_or_Strength Arg1:T18 Arg2:T58	
R27	Before Arg1:T41 Arg2:T18	
R28	Before Arg1:T44 Arg2:T20	
R29	Overlap Arg1:T20 Arg2:T21	
R30	Has_Route_or_Mode Arg1:T22 Arg2:T60	
R31	Combined_with Arg1:T22 Arg2:T23	
R32	Used_for Arg1:T22 Arg2:T21	
T74	CONC 1158 1181	variables hemodinámicas
R33	Location_of Arg1:T24 Arg2:T45	
R34	Overlap Arg1:T29 Arg2:T46	
R35	Overlap Arg1:T28 Arg2:T46	
R36	Overlap Arg1:T27 Arg2:T46	
R37	Overlap Arg1:T45 Arg2:T46	
R38	Overlap Arg1:T74 Arg2:T46	
R39	After Arg1:T74 Arg2:T46	
R40	After Arg1:T45 Arg2:T46	
R41	After Arg1:T27 Arg2:T46	
R42	After Arg1:T28 Arg2:T46	
R43	After Arg1:T29 Arg2:T46	
R44	Experiences Arg1:T62 Arg2:T31	
R45	Experiences Arg1:T62 Arg2:T19	
R46	Before Arg1:T31 Arg2:T19	
R47	Before Arg1:T31 Arg2:T32	
R48	Experiences Arg1:T62 Arg2:T32	
R49	Experiences Arg1:T63 Arg2:T19	
R50	Experiences Arg1:T63 Arg2:T32	
R51	Experiences Arg1:T63 Arg2:T51	
R52	Experiences Arg1:T62 Arg2:T51	
R53	Used_for Arg1:T33 Arg2:T51	
T75	Quantifier_or_Qualifier 1595 1617	8 intervalos de tiempo
R54	Has_Quantifier_or_Qualifier Arg1:T64 Arg2:T75	
T76	CONC 1635 1652	datos bioquímicos
R55	Experiences Arg1:T67 Arg2:T34	
R56	Has_Route_or_Mode Arg1:T34 Arg2:T68	
T77	Observation 1779 1803	estabilidad hemodinámica
#68	AnnotatorNotes T77	C4718759; Hemodynamic stability; Finding
R58	Experiences Arg1:T67 Arg2:T77	
R59	Causes Arg1:T34 Arg2:T77	
R60	Experiences Arg1:T67 Arg2:T35	
R61	Before Arg1:T34 Arg2:T35	
R62	Experiences Arg1:T67 Arg2:T55	
R63	Used_for Arg1:T36 Arg2:T55	
R64	Has_Route_or_Mode Arg1:T36 Arg2:T70	
R65	Before Arg1:T31 Arg2:T33	
R66	Combined_with Arg1:T34 Arg2:T36	
#69	AnnotatorNotes T8	C0035110; Repeat Surgery; Therapeutic or Preventive Procedure
R18	Experiences Arg1:T67 Arg2:T69	
R57	Before Arg1:T34 Arg2:T55	
A3	Experiencer T48 Patient
A4	Experiencer T52 Patient
A5	Experiencer T53 Patient
A6	Experiencer T57 Patient
A7	Experiencer T62 Patient
A8	Experiencer T63 Patient
A9	Experiencer T67 Patient
